Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Wilkinson

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Arthritis & Rheumatology (Hoboken, N.J.)|May 3, 2017
Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple MechanismsDavid J Wilkinson, Hui Wang, Angela Habgood, et al.
Scientific Reports|December 3, 2017
The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnoverDavid J Wilkinson, Antoine Desilets, Hua Lin, et al.
Nature Chemical Biology|December 24, 2005
Monocarboxylate transporter MCT1 is a target for immunosuppressionClare M Murray, Raymond Hutchinson, John R Bantick, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Arthritis & Rheumatology (Hoboken, N.J.)|May 3, 2017
Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple MechanismsDavid J Wilkinson, Hui Wang, Angela Habgood, et al.
Scientific Reports|December 3, 2017
The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnoverDavid J Wilkinson, Antoine Desilets, Hua Lin, et al.
Nature Chemical Biology|December 24, 2005
Monocarboxylate transporter MCT1 is a target for immunosuppressionClare M Murray, Raymond Hutchinson, John R Bantick, et al.
Pageof 6